Rosenverse
Digital Medicine Design

Log in or create a free Rosenverse account to watch this video.

Log in Create free account

100s of community videos are available to free members. Conference talks are generally available to Gold members.

Digital Medicine Design

Thursday, September 26, 2019 • Enterprise Community
Share the love for this talk
Digital Medicine Design
Speakers: Daniel J. Rosenberg
Link:

Summary

Can a software only mobile solution outperform a pharmaceutical drug in clinical trials? Is it possible to create an app only available via a doctor’s prescription? The answer to both questions is a responding YES! In this webinar, Dan walked through several medical product case studies he has consulted on. The first is the WellDoc BlueStar solution for type 2 diabetes patients. BlueStar was the first instance of Digital Medicine invented. BlueStar received both an FDA class 2 certification and a prescription drug code for insurance reimbursement. Legally speaking this 100% software only solution is a medication. In clinical trials it has proven to reduce high-risk type 2 patients A1C levels by more than 1.8 points, outperforming many commonly prescribed medications. The second case study is Bigfoot Biomedical’s artificial pancreas for type 1 diabetics. It has completed its first clinical trial rounds but is not yet in the market. This solution uses an amazing combination of AI, big data and IoT embedded in the human body to automate insulin delivery 24/7. The primary UX resides on the patients’ phone. Interfaces for doctors and insurance companies will complete the end to end system experience including an innovative direct to patients supply chain. In addition to these amazing case studies this webinar described the similarities between digital medicine design and Enterprise UX. You will be surprised to see how much they have in common as well as what else you need to know to enter this cutting-edge UX domain.

Key Insights

  • Digital medicine apps like BlueStar are prescription-only and undergo FDA clearance, making them legally a pharmaceutical class.

  • Only a tiny fraction (about 0.01%) of diabetes apps are FDA-cleared to ensure clinical effectiveness.

  • BlueStar outperforms metformin in lowering A1C by about 2 points through data science and gamification.

  • Bigfoot’s artificial pancreas integrates continuous glucose monitoring with an insulin pump controlled by smartphone, allowing personalized insulin dosing.

  • Medical UX design involves multi-actor systems including patients, caregivers, doctors, payers, pharmacies, and must consider HIPAA regulations.

  • The onboarding and provisioning processes in medical software are far more complex than in enterprise software due to prescriptions, insurance, and regulatory needs.

  • Safety is always the top design priority in digital medicine, followed by privacy and usability.

  • FDA agile process is highly regulated and closer to waterfall with strong documentation and traceability requirements, especially for higher-risk devices.

  • Contextual data like elevation, temperature, and activity levels can personalize insulin dosing algorithms in digital medicine products.

  • User retention issues in medical apps can sometimes mean success, as patients stop using the app after achieving stable health control.

Notable Quotes

"Digital medicine apps are legally considered a pharmaceutical, available by prescription only."

"About 200,000 digital health products exist, but only 1% of 1% have FDA clearance for accuracy."

"BlueStar lowered users' A1C by 2 points, outperforming the most common drug metformin which averages 1.5."

"If the phone dies, Bigfoot’s insulin pump continues working independently, but without new data input."

"You have to keep the injection sites moving because of scar tissue, adding to the body hacking complexity."

"Safety is your number one concern, privacy is your number two, and usability is number three."

"A lot of these companies have founders or investors who are themselves doctors or diabetic patients."

"Design history files must document every design decision for FDA audits—it's far more rigorous than typical usability tests."

"The FDA-approved agile process is more like a controlled waterfall with strict traceability, especially for Class 3 devices."

"If patients stop using the app because they’ve got their health under control, that’s like a dating app success — they got married, not that the app failed."

Ask the Rosenbot
Jack Moffett
SAFe or Sorry?
2019 • Enterprise Community
Ariel Kennan
Building a Design Culture
2017 • Enterprise Experience 2017
Gold
Maria Giudice
Empowering change: Reigniting purpose, passion and impact in research
2025 • Advancing Research 2025
Gold
James Lang
Hopeful Futures for UX Research
2026 • Rosenfeld Community
Nalini P. Kotamraju
An Organizational Story: Salesforce Lightning Design System
2016 • Enterprise UX 2016
Gold
Lada Gorlenko
Theme 3: Introduction
2021 • Design at Scale 2021
Gold
Briana Thomas
When Design Ops Comes in H.O.T. : A Tale of a Transformed Design Org
2021 • DesignOps Summit 2021
Gold
Cassini Nazir
The Dangers of Empathy: Toward More Responsible Design Research
2023 • Advancing Research 2023
Gold
Josh Clark
Sentient Design: New Design Patterns for New Experiences (3rd of 3 seminars)
2025 • Rosenfeld Community
Frances Yllana
The Big Question about Impact: A Panel Discussion
2024 • DesignOps Summit 2024
Gold
Maria Giudice
Remaking the Making Company: Moving from Product to Experience
2016 • Enterprise UX 2016
Gold
Maverick Chan
From Doodle to Demo: AI as Our Storytelling Partner
2025 • Rosenfeld Community
Tutti Taygerly
Make Space to Lead
2021 • Design at Scale 2021
Gold
Sam Proulx
Mobile Accessibility: Why Moving Accessibility Beyond the Desktop is Critical in a Mobile-first World
2022 • DesignOps Summit 2022
Gold
Holly Cole
Understanding Experiences: When you have to do more than work
2018 • DesignOps Summit 2018
Gold
Megan Blocker
A Selectively Scrappy Approach to ResearchOps
2018 • DesignOps Summit 2018
Gold

More Videos

Nathan Shedroff

"Reading books and articles is no longer central for many young people. What will replace books and articles for collective knowledge building?"

Nathan Shedroff Hugh Dubberly Thomas J. McLeish

How Will Design be Taught When the Schools Shut Down?

May 8, 2026

John Paul de Guzman

"We can forecast delivery dates despite shifting and volatile project conditions with 95% efficiency."

John Paul de Guzman

10k Screens Later: How We Became a Data-Driven Design Organization

September 24, 2024

Aleksandra Korczynska

"The key to combating survey fatigue is short surveys triggered at the right context, making respondents feel listened to and valued."

Aleksandra Korczynska Caroline Jarrett Justyna Parmee

Survey Tools

March 12, 2026

Kristin Skinner

"What are some of the metrics that you’ll use to measure the health of your teams and practice?"

Kristin Skinner

Theme 2: Introduction and Provocation

January 8, 2024

Rachael Dietkus, LCSW

"The conference is a single track, so everyone listens to the same content together, fostering community focus."

Rachael Dietkus, LCSW Victor Udoewa Jennifer Strickland

Everything You Need to Know about the Civic Design 2022 Call for Presentations

May 17, 2022

Uday Gajendar

"Creative provocation isn’t about building those crazy ideas but opening space for questioning assumptions."

Uday Gajendar

The Rise of Meta-Design: A Starter Playbook

May 19, 2022

Vanessa Varin

"Strong teams don't serve weak feedback."

Vanessa Varin

Feedback: The Other F-Word

September 10, 2025

Hugh Dubberly

"Horst Rittel introduced wicked problems to describe problems where consensus on definition is difficult, and calling them problems can be misleading—maybe they’re better called messes or tangles."

Hugh Dubberly

Problems with Problems: Reconsidering the Frame of Designing as Problem-Solving

June 19, 2019

Sean McKay

"Research isn't about collecting insights, it’s about shaping how teams think."

Sean McKay

Coexisting with non-researchers: Practical strategies for a democratized research future

March 11, 2025